# Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus

> **NCT00010413** · PHASE2 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 35 (—)

## Conditions studied

- Pemphigus

## Interventions

- **DRUG:** cyclophosphamide
- **DRUG:** filgrastim

## Key facts

- **NCT ID:** NCT00010413
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-04
- **Primary completion:** 2007-08
- **Final completion:** —
- **Target enrollment:** 35 (—)
- **Last updated:** 2008-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00010413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00010413, "Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00010413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*